Primary intracranial dural lymphoma of mucosa-associated lymphoid tissue (MALT) type: report of one case and review of the literature.

Détails

ID Serval
serval:BIB_D234D3407DDA
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Primary intracranial dural lymphoma of mucosa-associated lymphoid tissue (MALT) type: report of one case and review of the literature.
Périodique
Bulletin du Cancer
Auteur⸱e⸱s
George A.C., Ozsahin M., Janzer R., Agassis S., Meuli R., Baur A.S., Frossard V., Leyvraz S., Ketterer N.
ISSN
1769-6917 (Electronic)
ISSN-L
0007-4551
Statut éditorial
Publié
Date de publication
07/2005
Volume
92
Numéro
7
Pages
E51-E56
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: ppublish
Résumé
Primary indolent leptomeningeal lymphoma is a rare entity, and corresponds in most cases to mucosa-associated lymphoid tissue (MALT) type lymphoma. We are reporting a case of a 75 years old woman, who presented with a 2-year history of behavioral disorder, progressive memory loss and aphasia. Neuroimaging showed a mass infiltrating the frontal circumvolutions and the roof of the orbit. The biopsy revealed an infiltration of the dura by an indolent lymphoma, characteristic of a MALT-type lymphoma. Complete staging work-up did not show any evidence of systemic involvement. A treatment with systemic methotrexate, combined with intrathecal chemotherapy and followed by radiotherapy (30,6 Gy) of the primary site, was conducted. The 3-year follow-up confirms the persistent remission, the patient remaining well and free of symptoms. The review of the literature highlights the importance to recognize the indolent PLML as a distinct clinical entity, which exhibits a rather good prognosis following a relatively non-toxic therapy.
Mots-clé
Aged, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Combined Modality Therapy, Cytarabine/administration & dosage, Dura Mater, Female, Humans, Hydrocortisone/administration & dosage, Lymphoma, B-Cell, Marginal Zone/cerebrospinal fluid, Lymphoma, B-Cell, Marginal Zone/pathology, Meningeal Neoplasms/cerebrospinal fluid, Meningeal Neoplasms/pathology, Methotrexate/administration & dosage
Pubmed
Création de la notice
08/04/2008 15:48
Dernière modification de la notice
20/08/2019 16:52
Données d'usage